Combination therapy in the treatment of major depressive disorder complicated by fibromyalgia and menopause

Psychosomatics

Volumn 43, Issue 6, 2002, Pages 491-493

  Clayton, Anita H ^a,b   Kaltsounis Puckett, Juliana ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CODEINE; COTRIMOXAZOLE; DESIPRAMINE; ESTROGEN; FLUOXETINE; HALOTHANE; INDOMETACIN; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; VENLAFAXINE;

ADULT; ANGER; ANTICHOLINERGIC EFFECT; APATHY; APPETITE DISORDER; ARTICLE; CASE REPORT; CHRONIC PAIN; COUGHING; DEPRESSION; DRUG HYPERSENSITIVITY; FATIGUE; FEMALE; FIBROMYALGIA; HOT FLUSH; HUMAN; LIBIDO DISORDER; LIVER FAILURE; MEMORY DISORDER; MENOPAUSE; MOOD DISORDER; MUSCLE WEAKNESS; PERIPHERAL EDEMA; SLEEP DISORDER; SOMATIZATION; VERTIGO; VISUAL IMPAIRMENT;

EID: 0036841573     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.43.6.491     Document Type: Letter

References (26)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172
2. Goldenberg DL: Fibromyalgia syndrome a decade later: What have we learned? Arch Intern Med 1999; 159:777-785
3. Waxman J, Zatskis SM: Fibromyalgia and menopause: Examination of the relationship. Postgrad Med J 1986; 80:165-171
4. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP: The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997; 40:1928-1939
5. Korszun A, Young EA, Engleberg NC, Masterson L, Dawson EC, Spindler K, McClure LA, Brown MB, Crofford LJ: Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27:1526-1530
6. Neeck G, Crofford LJ: Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26:989-1002
7. Hassett AL, Cone JD, Patella SJ, Sigal LH: The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000; 43:2493-2500
8. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, Ackenheil M: Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42:2482-2488
9. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35:550-556
10. Lynch MD: Antidepressants as analgesics: A review of randomized controlled trials. J Psychiatry Neurosci 2001; 26:30-36
11. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison W, Keller MB: Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000; 157:1445-1452
12. Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD: Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990; 26:311-315
13. Smith DW, Eison MS, Riblet DA, et al: Analgesic properties of BMY 13754, a nontricyclic antidepressant candidate. Abstracts of the Society for Neuroscience 1983; 9:427
14. Pick CG, Paul D, Eison MS, Pasternak GW: Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 1992; 211:375-381
15. Goodnick PJ, Breakstone K, Kumar A, Freund B, DeVane CL: Nefazodone in diabetic neuropathy: Response and biology (letter). Psychosom Med 2000; 62:599-600
16. Dwight MM, Arnold LM, O’Brien H, Metzger R, Morris-Park E, Keck PE Jr: An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998; 39:14-17
17. Schreiber S, Backer MM, Pick CG: The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999; 273:85-88
18. Abbott FV, Hong Y, Blier P: Activation of 5HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 1996; 35:99-110
19. Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J: Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1996; 35:1314-1321
20. Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L: Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 2001; 40:307-314
21. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282-288
22. Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL: Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 1983; 44:130-133
23. de Novaes Soares C, Almeida OP, Joffe H, Cohen LS: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58:529-534
24. Avis NE, Crawford S, Stellato R, Longcope C: Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001; 4:243-249
25. Joffe H, Groninger H, Soares C, Nonacs R, Cohen LS: An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J Womens Health Gend Based Med 2001; 10:999-1004
26. Paoletti AM, Floris S, Mannias M, Orru M, Crippa D, Orlandi R, Del Zompo MM, Melis GB: Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause. J Clin Endocrinol Metab 2001; 86:608-612